Trial site
Szpital Miejski Sw. Jana Pawla II w Elblagu
- 5running trials
- 8closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis7 trials
- Crohn's disease4 trials
- Gastroparesis1 trial
- Phase
- Phase 26 trials
- Phase 36 trials
- Phase 41 trial
- Status
- Completed8 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Cinclus Pharma Holding AB2 trials
- Hoffmann-La Roche2 trials
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2 trials
- Alimentiv Inc.1 trial
- Anaptysbio Inc.1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
Closed trials
Withdrawn
Completed
Completed
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis
Completed
Completed
Completed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Completed
Determination of the Optimal Treatment Target in Ulcerative Colitis
Site data: ClinicalTrials.govUpdated 17 Nov 2026